| COR | LOE | RECOMMENDATIONS |
|---|---|---|
| 2a | B-NR | 1. For patients with a device-detected atrial high-rate episode (AHRE) lasting ≥24 hours1 and with a CHA2DS2-VASc score ≥2 or equivalent stroke risk,2 it is reasonable to initiate oral anticoagulation3 within a SDM framework that considers episode duration and individual patient risk. |
| 2b | B-NR | 2. For patients with a device-detected AHRE lasting between 5 minutes and 24 hours and with a CHA2DS2-VASc score ≥3 or equivalent stroke risk,2 it may be reasonable to initiate anticoagulation within a SDM framework that considers episode duration and individual patient risk. |
| 3: No Benefit | B-NR | 3. Patients with a device-detected AHRE lasting <5 minutes and without another indication for oral anticoagulation should not receive oral anticoagulation.4,5 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.